Utilizing state-of-the-art methodologies in protein production, biophysics and structural biology to facilitate structure-based drug discovery, screening and protein characterization.
State-of-the-art biophysical tools for high-throughput compound library screens
Hit validation using orthogonal biophysical/ biochemical workflows
Identification of binding sites using X-ray crystallography (PanDAA)
Refined crystal structure to define SAR and inform compound design & optimization
High-throughput screening of therapeutic target proteins
Unique analytics based workflows for biophysical characterization of monoclonal antibodies, bispecific antibodies, and nanobodies (mAbs/ BsAbs/ nbs) and various therapeutic target proteins
Early determination of binding affinity, thermostability and aggregation profile allow for robust, up-front decision making
96-well based expression and purification platform allows for faster decision making with rapid turnaround times
Notice: Undefined index: content_position in /var/www/html/wp-content/plugins/premium-addons-pro/widgets/premium-image-accordion.php on line 1656
Seamless integration of multiple disciplines
Gene to Protein services for biochemical / biophysical studies
State of the art facility at Harwell Research Complex for (RcCaH) and Diamond Light Source (DLS)
Gene design – protein expression & purification (small scale to large scale)
QC – identification and confirmation of the protein state and stability
Gene to structure (X-ray crystallography/ Cryo-EM)
Protein/ protein-ligand structure generation
High resolution data for the target protein
Structure based Drug Design (SBDD)
World class synchrotron facility access (Diamond Light Source)
Cryo-EM method of choice for large proteins or protein complexes
What can Arctoris do?
Our capabilities and assays
Protein Production
Protein expression, purification and bio-conjugation
Established expression platform optimized for your protein
High quality, assay-ready proteins with comprehensive QC (Mass spectrometry (MS), Analytical size-exclusion chromatography (aSEC), Thermostability/ Dynamic light scattering ( DLS)
Bioconjugation of proteins with optimized tags for downstream assays
Structural Biology
Physical quantification of protein structure and interactions with ligands
High-throughput robotic crystallization platform with access to Diamond Light Source
High-throughput fragment soaking platform
Outstanding experience across multiple protein classes from membrane proteins to biologics
Biophysics
Characterization of molecular interactions
Protein aggregation, oligomeric status, KD, on-,off-rates, ΔH
High-throughput ligand screening using orthogonal technologies, kinetic analysis of top hits, EC50 determination and sample purity analysis
Gene constructs designed in alignment with downstream structural/ biophysical/ biochemical applications
Diverse tagging strategies to improve expression issues and purification
Protein expression
Established expression platforms for soluble, secreted and membrane proteins, mAbs and bispecific antibodies, proteins from inclusion bodies (refolding)
E. coli, mammalian, insect, BacMam & cell-free expression platforms
Small scale expression followed by analytical screening to identify best candidates for large scale prep
Large-scale expression (100lt/week)
Protein purification
High-throughput small-scale purification to determine best purification conditions (DoE/ Design of Experiment)
Large scale protein purification using different affinity techniques such as Immobilized metal affinity chromatography (IMAC)/ Cleavage/ sub-IMAC/ Ion Exchange Chromatography (IEX)/ Size Exclusion Chromatography (SEC)
QC analysis of purified protein (SDS-PAGE, differential scanning fluorimetry (DSF),Dynamic light scattering (DLS), analytical size exclusion chromatography (aSEC), Mass Spectrometry (MS), Peptide mass fingerprinting (PMF)
Optimization & generation of diffractable crystals
Apo crystals
Co-crystals
Lipidic Cubic Phase (LCP)
Protein-protein/ antibodies/ nanobodies
Crystals mounting, X-ray screening and data collection
Molecular replacement (MR)
Multiple isomorphous replacement (MIR)
Multiple wavelength anomalous dispersion (MAD)
Data analyses and and structure determination
Phase determination
Model Building and refinement
Structure guided ligand design/ protein engineering
We use cookies to ensure that we give you the best experience on our website. Click on 'Accept' to consent to all cookies, 'Reject' to only use stricly necessary cookies, or 'Learn more' to read our Cookie Policy.AcceptRejectLearn more